These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6679286)

  • 1. Early treatment with AT III in acute liver failure.
    Vogel GE
    Behring Inst Mitt; 1983 Aug; (73):79-93. PubMed ID: 6679286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Consumption coagulopathies following peritoneojugular bypass. Prevention by a heparin-antithrombin III combination].
    Peyrin JC; Waldmann V; Girardet P; Pouzol P; Duret J; Fargnoli JM; Magne JL; Perron Y
    J Chir (Paris); 1986; 123(6-7):417-23. PubMed ID: 3771670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatic coagulopathy--principles and therapeutic statements].
    Thaler E; Kleinberger G
    Leber Magen Darm; 1982 Oct; 12(5):193-7. PubMed ID: 7182699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy with antithrombin III concentrate].
    Vinazzer H
    Haematologica; 1990; 75 Suppl 2():14-20. PubMed ID: 2201604
    [No Abstract]   [Full Text] [Related]  

  • 5. [Place of antithrombin III concentrate in the intensive care of disseminated intravascular coagulation].
    Vorob'eva NA; Neporada EL; Turundaevskaia OV; Mel'nikova GN
    Anesteziol Reanimatol; 2007; (2):42-4. PubMed ID: 17563999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin III infusion in patients undergoing peritoneovenous shunt operation: failure in the prevention of disseminated intravascular coagulation.
    Büller HR; ten Cate JW
    Thromb Haemost; 1983 Apr; 49(2):128-31. PubMed ID: 6868009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children.
    Hanada T; Abe T; Takita H
    Am J Pediatr Hematol Oncol; 1985; 7(1):3-8. PubMed ID: 4037242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children.
    Fuse S; Tomita H; Yoshida M; Hori T; Igarashi C; Fujita S
    Am J Hematol; 1996 Sep; 53(1):18-21. PubMed ID: 8813091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled trial of antithrombin III supplementation in fulminant hepatic failure.
    Langley PG; Hughes RD; Forbes A; Keays R; Williams R
    J Hepatol; 1993 Mar; 17(3):326-31. PubMed ID: 8315261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of fulminant hepatic failure on protein C antigen and activity.
    Langley PG; Williams R
    Thromb Haemost; 1988 Apr; 59(2):316-8. PubMed ID: 3388300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
    Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
    Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical importance of the determination of antithrombin III by the use of a chromogenic substrate, in cases of disseminated intravascular coagulation and of acute hepatic insufficiency].
    Carmignoto F; Schivo P; Plebani M; Pengo V; Piccini P; Ceriotti G
    Quad Sclavo Diagn; 1981 Jun; 17(2):172-81. PubMed ID: 7267980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor II related antigen and antithrombin III levels as indicators of liver failure in consumption coagulopathy.
    Sié P; Letrenne E; Caranobe C; Genestal M; Cathala B; Boneu B
    Thromb Haemost; 1982 Jun; 47(3):218-20. PubMed ID: 6810490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment effects of antithrombin-III on coagulation abnormalities in rats with endotoxaemia].
    Qiao YJ; Zhu JM; You XL; Zhang Y
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Mar; 19(3):165-7. PubMed ID: 17376272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Substitution of antithrombin III in shock patients].
    Blauhut B; Necek S; Vinazzer H; Bergmann H
    Anaesthesist; 1982 Jul; 31(7):349-52. PubMed ID: 7125179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of antithrombin administration in the acute phase of burn injury.
    Lavrentieva A; Kontakiotis T; Bitzani M; Parlapani A; Thomareis O; Scourtis H; Tsotsolis N; Lazaridis L; Giala MA
    Thromb Haemost; 2008 Aug; 100(2):286-90. PubMed ID: 18690349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the fibrinolytic system in patients with fulminant liver failure.
    Pernambuco JR; Langley PG; Hughes RD; Izumi S; Williams R
    Hepatology; 1993 Dec; 18(6):1350-6. PubMed ID: 8244260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
    Rodríguez Gómez M; López Fernández MF; Batlle J
    Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The initial experience of antithrombin III in the management of neonates with necrotizing enterocolitis.
    St Peter SD; Little DC; Calkins CM; Holcomb GW; Snyder CL; Ostlie DJ
    J Pediatr Surg; 2007 Apr; 42(4):704-8. PubMed ID: 17448770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early intervention with antithrombin III therapy to prevent progression of hepatic venoocclusive disease.
    Peres E; Kintzel P; Dansey R; Baynes R; Abidi M; Klein J; Ibrahim RB; Abella E
    Blood Coagul Fibrinolysis; 2008 Apr; 19(3):203-7. PubMed ID: 18388499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.